ClinicalTrials.Veeva

Menu

The Effects of Chicken Extract on Mental Energy in Healthy Adults and the Underlying Mechanisms

B

Brand's Suntory Asia

Status

Completed

Conditions

Healthy Adults

Treatments

Dietary Supplement: Chicken extract supplement (low-dose)
Dietary Supplement: Chicken extract supplement (high-dose)
Other: Placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06021223
BEC-002

Details and patient eligibility

About

This exploratory trial investigates the effect of a chicken extract supplement on mental energy and its potential underlying mechanisms of action among healthy adults using a randomized, double-blind, placebo-controlled clinical trial design. Mental energy is a multi-dimensional construct comprising transient feelings about fatigue, vigor and motivation and cognitive performance in terms of sustained attention and reaction time.

A sub-study investigates the immediate biochemical changes after taking chicken extract.

Enrollment

189 patients

Sex

All

Ages

35 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female at 35-64 years of age
  • Assessed by investigator to be in good health
  • Normal cognition based on investigator's clinical judgement per the routine practice
  • Modified PSQI score > 5
  • Agree to participate in the study and provide written informed consent
  • Agree to abstain from herbal extracts or dietary supplements throughout the study period

Exclusion criteria

  • BMI < 18.5 or ≥ 27 kg/m2
  • Concurrent pharmacological treatments
  • Current systemic diseases or current/history of neurological or cerebrovascular diseases
  • Active peptic ulcer, or a history of peptic ulcer within the last 2 years
  • Medications or interventions in the last 4 weeks, which in the investigators' judgement could potentially affect the outcome measures
  • Regular significant quantities of dietary supplements or herbal extracts (> 2 times a week) in the last 4 weeks
  • Regular excessive caffeine consumption, heavy alcohol consumption or heavy habitual smokers
  • Any drastic changes in lifestyle (including diet, smoking, sleep, exercise, and mental and physical activities) in the last 4 weeks
  • Not able to maintain the same lifestyle throughout the study period
  • Inadequate visual and auditory acuity to allow neuropsychological testing per investigator's judgment
  • Inability to undergo fMRI scan
  • Any consumption of chicken extract supplement, or carnosine or anserine supplement, in the preceding 4 weeks
  • History of allergy to caseinate, milk, or chicken meat
  • Women who are pregnant or lactating or intending to do so
  • Current enrolment in another interventional study
  • Subjects who show unstable sleep habits during the previous month
  • Excessive blood donation or blood drawn prior to baseline

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

189 participants in 3 patient groups, including a placebo group

Chicken extract supplement (high-dose)
Experimental group
Description:
140ml of chicken extract supplement (high-dose) to be consumed daily for 2 weeks
Treatment:
Dietary Supplement: Chicken extract supplement (high-dose)
Chicken extract supplement (low-dose)
Experimental group
Description:
140ml of chicken extract supplement (low-dose) to be consumed daily for 2 weeks
Treatment:
Dietary Supplement: Chicken extract supplement (low-dose)
Placebo
Placebo Comparator group
Description:
140ml of placebo (caesinate) to be consumed daily for 2 weeks
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Lee Cheng Phua, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems